Stress-specific 14-3-3-client modules in digestive cancers: an evidence-graded review of adaptive survival and

Rudong Li1, Zhipeng Zhao1, Xudong Wang1

  • 1Department of Gastrointestinal Nutrition and Hernia Surgery, The Second Hospital of Jilin University, Changchun, Jilin, People's Republic of China.

Insights

Stress-specific 14-3-3 protein interactions, not total levels, are key in cancers. These modules influence cell death, stress responses, and treatment resistance across various gastrointestinal cancers.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cellular Stress Response

Background:

  • 14-3-3 proteins are crucial adaptors regulating cellular processes under stress.
  • Dysregulation of 14-3-3 interactions is implicated in various cancers.
  • Understanding specific 14-3-3-client modules is vital for cancer research.

Purpose of the Study:

  • To review and synthesize stress-specific 14-3-3 protein-client interactions in major gastrointestinal cancers.
  • To classify these modules based on mechanistic and clinical evidence.
  • To highlight the clinical relevance of specific complexes over total protein expression.

Main Methods:

  • Narrative review of existing literature.
  • Classification of 14-3-3-client modules based on mechanistic evidence, functional perturbation, client mapping, treatment-state validation, and clinical association.
  • Synthesis of findings across gastric, colorectal, pancreatic, and hepatobiliary cancers.

Main Results:

  • Identified distinct stress-specific 14-3-3-client modules in gastric, colorectal, and pancreatic cancers.
  • In gastric cancer, 14-3-3ζ-G3BP1 retains Bax, inhibiting apoptosis.
  • In colorectal cancer, 14-3-3σ-SFN sustains unfolded protein response and chemoresistance.
  • In pancreatic cancer, 14-3-3σ-SFN promotes gemcitabine resistance via YAP1 and ribonucleotide reductase.
  • Hepatobiliary cancer modules show context-dependent anoikis resistance.

Conclusions:

  • Clinically relevant units are stress-specific 14-3-3-client complexes, not overall 14-3-3 expression levels.
  • These specific modules play significant roles in cancer progression and treatment response.
  • Targeting these defined modules offers potential therapeutic strategies in gastrointestinal cancers.

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...